A M Vogel

Summary

Affiliation: Middlemore Hospital
Country: New Zealand

Publications

  1. ncbi Palivizumab prophylaxis of respiratory syncytial virus infection in high-risk infants
    A M Vogel
    University of Auckland, Wellington, New Zealand
    J Paediatr Child Health 38:550-4. 2002
  2. ncbi Variations in bronchiolitis management between five New Zealand hospitals: can we do better?
    A M Vogel
    Department of Paediatrics, South Auckland Clinical School, University of Auckland, Starship Children s Hospital, Auckland, New Zealand
    J Paediatr Child Health 39:40-5. 2003
  3. ncbi Intended plans for breastfeeding duration: a simple tool to predict breastfeeding outcome
    A M Vogel
    South Auckland Health, Otahuhu, South Auckland, New Zealand
    Acta Paediatr 92:270-1. 2003
  4. ncbi Cost-effectiveness of palivizumab in New Zealand
    A M Vogel
    Department of Paediatrics, University of Auckland, New Zealand
    J Paediatr Child Health 38:352-7. 2002
  5. ncbi The establishment and duration of breastfeeding. Part 2: Community influences
    A M Vogel
    Department of Paediatrics, School of Medicine, University of Auckland, New Zealand
    Breastfeed Rev 6:11-6. 1998
  6. ncbi The impact of pacifier use on breastfeeding: a prospective cohort study
    A M Vogel
    Department of Paediatrics, The University of Auckland, Auckland, New Zealand
    J Paediatr Child Health 37:58-63. 2001
  7. doi Respiratory health outcomes 1 year after admission with severe lower respiratory tract infection
    A A Trenholme
    The University of Auckland, Middlemore Hospital, Auckland, New Zealand
    Pediatr Pulmonol 48:772-9. 2013
  8. ncbi The establishment and duration of breastfeeding. Part 1: Hospital influences
    A M Vogel
    Department of Paediatrics, School of Medicine, University of Auckland
    Breastfeed Rev 6:5-9. 1998
  9. ncbi Molecular characterization of the melanocyte lineage-specific antigen gp100
    G J Adema
    Division of Immunology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Huis, Amsterdam
    J Biol Chem 269:20126-33. 1994

Collaborators

Detail Information

Publications9

  1. ncbi Palivizumab prophylaxis of respiratory syncytial virus infection in high-risk infants
    A M Vogel
    University of Auckland, Wellington, New Zealand
    J Paediatr Child Health 38:550-4. 2002
    ..The consensus panel recommends that the priority for palivizumab be given to babies discharged on home oxygen with chronic lung disease, followed by babies born at 28 weeks or less gestation...
  2. ncbi Variations in bronchiolitis management between five New Zealand hospitals: can we do better?
    A M Vogel
    Department of Paediatrics, South Auckland Clinical School, University of Auckland, Starship Children s Hospital, Auckland, New Zealand
    J Paediatr Child Health 39:40-5. 2003
    ..To determine the current management of bronchiolitis by five major New Zealand hospitals and to identify areas for improvement...
  3. ncbi Intended plans for breastfeeding duration: a simple tool to predict breastfeeding outcome
    A M Vogel
    South Auckland Health, Otahuhu, South Auckland, New Zealand
    Acta Paediatr 92:270-1. 2003
    ..This provides a tool to establish the risks for short duration of breastfeeding. Conclusion: It is necessary to identify the factors that influence mothers' plans, and to find means to intervene effectively...
  4. ncbi Cost-effectiveness of palivizumab in New Zealand
    A M Vogel
    Department of Paediatrics, University of Auckland, New Zealand
    J Paediatr Child Health 38:352-7. 2002
    ..To establish the preterm infant hospitalization risks from respiratory syncytial virus (RSV) in New Zealand and the net cost per hospitalization averted by palivizumab...
  5. ncbi The establishment and duration of breastfeeding. Part 2: Community influences
    A M Vogel
    Department of Paediatrics, School of Medicine, University of Auckland, New Zealand
    Breastfeed Rev 6:11-6. 1998
    ..Conflicting opinions exist about the difficulties of introducing older infants to bottles...
  6. ncbi The impact of pacifier use on breastfeeding: a prospective cohort study
    A M Vogel
    Department of Paediatrics, The University of Auckland, Auckland, New Zealand
    J Paediatr Child Health 37:58-63. 2001
    ..To determine the predictors of pacifier use during the first year of life and to assess the influence of pacifier use on the duration of breastfeeding...
  7. doi Respiratory health outcomes 1 year after admission with severe lower respiratory tract infection
    A A Trenholme
    The University of Auckland, Middlemore Hospital, Auckland, New Zealand
    Pediatr Pulmonol 48:772-9. 2013
    ....
  8. ncbi The establishment and duration of breastfeeding. Part 1: Hospital influences
    A M Vogel
    Department of Paediatrics, School of Medicine, University of Auckland
    Breastfeed Rev 6:5-9. 1998
    ....
  9. ncbi Molecular characterization of the melanocyte lineage-specific antigen gp100
    G J Adema
    Division of Immunology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Huis, Amsterdam
    J Biol Chem 269:20126-33. 1994
    ..In all normal and malignant melanocytic cells analyzed, gp100 and Pmel17 RNAs are simultaneously expressed...